Healthcare Triangle, Inc.
No SEC Form 4 filings for $HCTI in the last 30 days.
See all $HCTI insider activity →Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement (the “Amendment”), which amends the Equity Purchase Agreemen
Healthcare Triangle (HCTI) signed a non-binding LOI to acquire Roboticom's industrial robotics business. Roboticom's 2025 revenue was $14.1M, with projections of $153.5M by 2029/30. HCTI may pay up to $30M in cash and equity. The deal aims to expand HCTI's tech platform into industrial automation.
Healthcare Triangle (HCTI) partners with Kanzun-ARCB Growth Fund to help Malaysian healthcare companies expand into U.S. markets. HCTI will provide AI, cloud, and data expertise. ARCB brings AED 300M in assets, while Kanzun leads deal sourcing in Malaysia.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning HCTI (Healthcare Triangle, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent HCTI coverage spans corporate actions, mergers & acquisitions and financial news.
Amendment may limit future equity dilution and set a higher floor price, potentially supporting share price.
The acquisition could diversify HCTI beyond healthcare into industrial automation, potentially boosting long‑term growth but also adding integration risk.
The partnership positions HCTI as a bridge for Malaysian health‑tech firms to access U.S. capital, potentially expanding HCTI's advisory revenue and market visibility.
The spin‑off creates a new publicly traded entity and may affect HCTI's valuation and liquidity.
The quarter shows strong post-acquisition momentum (Teyame and Datono) with margin expansion and a balance-sheet equity jump.
AlphAI scores every news story that mentions HCTI with an AI model for sentiment and relevance, and aggregates insider trades from Healthcare Triangle, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement (the “Amendment”), which amends the Equity Purchase Agreemen
1 min readHealthcare Triangle (HCTI) signed a non-binding LOI to acquire Roboticom's industrial robotics business. Roboticom's 2025 revenue was $14.1M, with projections of $153.5M by 2029/30. HCTI may pay up to $30M in cash and equity. The deal aims to expand HCTI's tech platform into industrial automation.
2 min readHealthcare Triangle (HCTI) partners with Kanzun-ARCB Growth Fund to help Malaysian healthcare companies expand into U.S. markets. HCTI will provide AI, cloud, and data expertise. ARCB brings AED 300M in assets, while Kanzun leads deal sourcing in Malaysia.
2 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 2, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into (i) a Separation and Distribution Agreement (the “Separation Agreement”) and (ii) a Transition Services Agreement
2 min readHealthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.
4 min readHealthcare Triangle (Nasdaq: HCTI) said it signed a non-binding LOI to acquire a 51% stake in CosmoInnovations (CosmoAesthetics Pty Ltd). Proposed consideration is $23.5 million over three years via cash, equity, and performance milestones. The deal would add 27 granted international patents and 61 pending applications, targeting over $50 million cumulative revenue in three years.
4 min readHealthcare Triangle, Inc. (Nasdaq: HCTI) said it completed on July 24, 2026 the issuance of 12,546,540 common shares tied to its Teyame AI LLC acquisition and a SecureKloud Technologies Ltd. share exchange. Shares outstanding rose to 14,644,322. The company cited Nasdaq’s new $5 million MVLS continued listing standard, estimating MVLS of about $23.87 million as of July 28, 2026.
4 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Exhibit 99.1 Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq’s New $5 Million Market Value Listing Standard Common shares outstanding increase to 14,644,322 following the closing of two previously approved tr
2 min readHealthcare Triangle, Inc. (NASDAQ: HCTI) said it appointed Sumit Ganguli as Chairman and CEO of Purpose Health, its wholly owned AI-led healthcare services subsidiary. Purpose Health will build AI infrastructure and managed services for providers, payors, and life sciences clients, targeting multi-year recurring revenue. The release cites Ganguli’s prior scaling to about $175M revenue (2009-2024).
3 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001839285 0001839285 2026-07-17 2026-07-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor
2 min read
